Listly by Robert Henric
[129 Pages Report] The central fill pharmacy automation market is projected to reach USD 656 million by 2024 from USD 381 million in 2019, at a CAGR of 11.5%. The increasing demand for specialty drugs being dispensed by central fill pharmacies is one of the primary drivers propelling the growth of this market.
[105 Pages Report] The fractional flow reserve market is projected to reach USD 1,082 million by 2024 from USD 516 million in 2019, at a CAGR of 16.0% during the forecast period. Growth in this market is primarily attributed to the rising geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, cost benefits of FFR, and the presence of a favorable reimbursement scenario for FFR.
[107 Pages Report] The regenerative medicine market is projected to reach USD 38.7 billion by 2024 from USD 13.3 billion in 2019, at a CAGR of 23.8%. Market growth is largely driven by the rising prevalence of chronic diseases and genetic disorders, growing government investments in regenerative medicine research, and the increasing number of regenerative medicine companies globally.
#medicine #regenerativemedicine
The global sugar excipients market is estimated to grow at a CAGR of 4.3% from 2016 to 2021 to reach USD 1,060.6 Million by 2021. Increasing use of co-processed excipients to improve the dissolution, bioavailability, and solubility of recently developed active pharmaceutical ingredients (APIs), rapid growth in the generics market due to the patent expiration of many blockbuster drugs
[126 Pages Report] The global kidney/renal function test market was valued at USD 558.3 Million in 2016 and expected to reach USD 790.1 Million by 2022, growing at a CAGR of 6.1% during the forecast period. Growth in the kidney function test market can primarily be attributed to factors such as the rising prevalence of kidney disease, growing prevalence of diabetes and hypertension, rapid growth in the geriatric population, and the rise in alcohol consumption are driving the growth of the market.
[141 Pages Report] The therapeutic drug monitoring market is projected to reach to reach USD 1.63 billion by 2023 from USD 1.16 billion in 2017 at a CAGR of 5.9% during the forecast period. The scope of the study includes the various consumables and equipment’s used to perform therapeutic drug monitoring assays. The base year considered for the study is 2017, and the forecast for the market size is provided for the period between 2018 and 2023.
[196 Pages Report] The global in vivo toxicology market was valued at USD 4.15 Billion in 2016 and is expected to grow at a CAGR of 6.9% during the forecast period to reach to USD 6.14 Billion by 2022. The base year considered for the study is 2016 and the forecast for the market size is provided for the period between 2017 and 2022. Factors such as increasing pharmaceutical R&D activities, mandatory government regulations for animal testing, innovations in animal models, and the development of exclusive in vivo toxicology tests are driving the growth of the global market.
[114 Pages Report] The global microservices in healthcare market is projected to reach USD 343.3 million by 2023 from the estimated USD 103.1 million in 2017, at a CAGR of 21.3%. The benefits of microservice architecture, such as their ability to increase overall efficiency and project delivery speed, are the primary factor driving the market growth. However, concerns regarding security and regulatory compliance and the complexity of architecture are expected to hinder the growth of this market.
[101 Pages Report] The global flexible & semi-rigid ureteroscopy market is expected to reach USD 1,054.1 million by 2023 from USD 768.0 million in 2017, at a CAGR of 5.4%.
[105 Pages Report] The fractional flow reserve market is projected to reach USD 1,082 million by 2024 from USD 516 million in 2019, at a CAGR of 16.0% during the forecast period. Growth in this market is primarily attributed to the rising geriatric population and the subsequent growth in the prevalence of cardiovascular diseases, cost benefits of FFR, and the presence of a favorable reimbursement scenario for FFR.
The Research Report on Central Fill Pharmacy Automation Marketprovides a detailed overview of the increasing demand for specialty drugs being dispensed by central fill pharmacies is one of the primary drivers propelling the growth of this market. Other factors such as the need to minimize medication errors, growing patient volume (which in turn is increasing the burden on pharmacies), and the growing focus on automation to reduce labor costs are also driving market growth.
The report "Fractional Flow Reserve Market by Technology (Invasive Monitoring, Non-invasive Monitoring), Invasive Monitoring, Product (Pressure Guidewires, FFR Measurement Systems), Application (Single-vessel Diseases, Multi-vessel Diseases) - Global Forecast to 2027", is projected to reach USD 1,223 million by 2027 from USD 516 million in 2019, at a CAGR of 12.3% during the forecast period (2019-2027).
The report "Central Fill Pharmacy Automation Market by Product (Equipment (Medication Dispensing System, Automated Medication Compounding Systems, Workflow Management), Service (Process Optimization, Facility Design), Software), Vendor - Global Forecast to 2027" is projected to reach USD 826 million by 2027 from USD 381 million in 2019, at a CAGR of 16.7%.
The oxygen therapy equipment market is expected to reach USD 4.01 Billion by 2022 from USD 2.65 Billion in 2017, at a CAGR of 8.7%. Growing incidence of respiratory diseases, growth in the elderly population, preference towards home-based oxygen therapy, and technological innovations are driving the growth of this market.
The single-cell analysis market is consolidated in nature due to the presence of a few large players. The prominent players in the single-cell analysis market include Thermo Fisher Scientific Inc. (U.S.)., Illumina, Inc, (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies (U.S.), Nanostring Technologies (U.S.),Beckman Coulter (U.S.), Fluidigm Corporation (U.S.), Merck KGaA (Germany) and QIAGEN N.V. (Netherlands).
[114 Pages Report] The dental syringes market is expected to reach USD 126.9 Million by 2021 from USD 98.5 Million in 2016, at a CAGR of 5.2% during the forecast period. Technological advancements in dental syringes, growth in geriatric population and government legislations to avoid needlestick injuries are adding to the growth prospects of this market.
[175 Pages Report] Single cell analysis market is estimated to grow at a CAGR of 16.5% during the forecast period, to reach USD 3.59 Billion by 2022. Growth of the market is primarily driven by the technological advancements in single cell analysis products, increasing government funding for cell-based research, growing biotechnology and pharmaceutical industries, wide applications of single cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases.
[175 Pages Report] Single cell analysis market is estimated to grow at a CAGR of 16.5% during the forecast period, to reach USD 3.59 Billion by 2022. Growth of the market is primarily driven by the technological advancements in single cell analysis products, increasing government funding for cell-based research, growing biotechnology and pharmaceutical industries, wide applications of single cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases.
According to MarketsandMarkets the viral clearance market is expected to reach USD 724.5 million by 2023 from USD 271.2 million in 2018, at a CAGR of 21.7%. Don�t miss out on business opportunities in In Viral Clearance Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
According to MarketsandMarkets the central fill pharmacy automation market is projected to reach USD 826 million by 2027 from USD 381 million in 2019, at a CAGR of 16.7%. Don�t miss out on business opportunities in Central Fill Pharmacy Automation Market. Speak to our analyst and gain crucial industry insights that will help your business grow.
The Global Viral Clearance Market is expected to reach USD 724.5 million by 2023 from USD 271.2 million in 2018… by gajananmnm
[129 Pages Report] The central fill pharmacy automation market is projected to reach USD 656 million by 2024 from USD 381 million in 2019, at a CAGR of 11.5%. The increasing demand for specialty drugs being dispensed by central fill pharmacies is one of the primary drivers propelling the growth of this market.
[164 Pages Report] Biobanking Market is expected to reach $2.69 billion by 2022 from $1.72 billion in 2016 at a CAGR of 7.8%. The base year for this study is 2016. The equipment segment is estimated to account for the largest share of the market in 2017. This is primarily attributed to the increasing number of biobanks and rising number of biosamples around the world, due to which the demand for equipment remains high.
[118 Pages Report] The global medical camera market is expected to reach USD 3.69 Billion by 2021 from USD 2.43 Billion in 2016, at a CAGR of 8.7% during the forecast period. The global market is segmented based on camera type, sensor, resolution, end user, and region.
Additive manufacturing is an automatic process used to create rapid prototypes and functional end-use parts. It takes virtual designs from Computer Aided Design (CAD) software, and transforms them into thin, virtual, horizontal layer-wise cross-sections, until the model is complete.